NCBiotech News

Diana De Leon, an 18-year-old recent Pitt County high school grad, is proof that satisfying, rewarding, career-worthy jobs are waiting for a wide range of North Carolinians in the field of pharmaceutical manufacturing. She's now employed at Thermo Fisher Scientific in Greenville.

Dallas-based Taysha Gene Therapies announced plans today to invest $75 million in a gene therapy manufacturing facility in Durham that will employ 201 people over the next three years.

Thermo Fisher Scientific will invest approximately $500 million and add 500 new jobs in Greenville over the next two years as it expands its sterile drug product development and commercial manufacturing of critical medicines, therapies and vaccines

A Thermo Fisher facility in Greenville that has become one of North Carolina’s largest pharmaceutical manufacturers, is getting another $74 million upgrade to support the growing global demand for biomanufacturing services and biologics products.

Newly released Seqirus data demonstrate the effectiveness and safety of its pandemic influenza A (H5N1) vaccine that it makes in cell culture at its massive manufacturing facility in Holly Springs.

The FDA has approved a once-daily capsule developed by Durham's BioCryst Pharmaceuticals to prevent the life-threatening attacks of swelling in people with the rare disease called hereditary angioedema, or HAE.

An NCBiotech contract drug development and manufacturing portfolio company, KBI Biopharma, will establish a new $150M, 200-employee manufacturing facility near RTP.

The North Carolina Biotechnology Center awarded 36 loans and grants totaling nearly $2.5 million to universities and bioscience companies during the fourth quarter of its 2015-2016 fiscal year ending June 30.

North Carolina’s life science sector grew four times faster than that of the rest of the nation over the last decade. Even so, a study of the state’s industry says the best is yet to come, as the state builds on its “SuperSciNCe” – its prodigious research and innovation strengths in such growing markets as medicine, agriculture, biomanufacturing and health informatics.

Site selection leaders huddled with more than 100 North Carolina economic development gurus recently in Raleigh for a Life Science Economic Development Summit organized by the North Carolina Biotechnology Center.

Not only is Novartis planning to expand its $1 billion Holly Springs biomanufacturing campus with a $47 million addition starting next month, but the Swiss global pharmaceutical giant is also about to open a new R&D operation in Research Triangle Park.
 

Heiri Gugger, Ph.D., speaks to NCBiotech Jobs Network audience.

Heiri Gugger, Ph.D., has turned another spotlight on North Carolina’s fast-growing global leadership in agricultural biotechnology.

 

Visit the North Carolina Biotechnology Center’s Funding Gateway page to get more information on funding announcements, links to opportunity search databases and grant development tips!

---

 

 

Visit the North Carolina Biotechnology Center’s Funding Gateway page to get more information on funding announcements, links to opportunity search databases, and grant development tips!

If your New Year’s resolution is to get out of a low-paying, dead-end job and make a move into a good-paying, fulfilling career in the biopharmaceutical industry, you need to attend the free BPD Spotlight on Education event this Thursday, January 17, from 12:30 to 4 p.m., at the North Carolina Biotechnology Center.